Skip to main content
. 2018 Nov 7;8:16471. doi: 10.1038/s41598-018-34576-4

Figure 2.

Figure 2

Vδ1+ cells in HIV controllers display an activated, effector-like phenotype. PBMCs were characterized by flow cytometry and the phenotypes of viable CD3+Vδ1+ cells were assessed. (a) Representative flow plots from an HIV-uninfected subject (Neg) and an elite controller (EC). The numbers in each quadrant represent the percentage of CD3+Vδ1+ cells. (bd) Summary data of median percentages of Vδ1+ cells that are CD45RA+CD27+ (b), CD45RA+CD27 (c), or HLA-DR+CD38+ (d) for Neg (n = 17), EC (n = 15), CT (n = 13), VC (n = 4), and CU (n = 11) subjects. The medians of the cohorts were significantly different for all three (b-d) summary graphs (p < 0.0001) as assessed by the Kruskal-Wallis test. Dunn’s multiple comparison tests were used to assess differences between HIV and HIV+ groups. *p < 0.05; **p < 0.01; ***p < 0.001.